Related Experiment Videos
Staphylokinase-specific cell-mediated immunity in humans.
Petra A M Warmerdam1, Kristel Vanderlick, Petra Vandervoort
1Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Campus Gasthuisberg O&N, Herestraat 49, 3000 Leuven, Belgium. petra.warmerdam@med.kuleuven.ac.be
Journal of Immunology (Baltimore, Md. : 1950)
|December 26, 2001
Summary
Staphylokinase, a clot-dissolving drug, triggers T cell responses and immunological memory. Identifying key immunogenic regions can help create less immunogenic variants for safer therapeutic use.
Area of Science:
- Immunology
- Biochemistry
- Pharmacology
Background:
- Staphylokinase is a fibrin-specific thrombolytic agent with bacterial origins.
- Most patients develop neutralizing antibodies (Ab) against staphylokinase.
- The immunogenic features driving these antibody responses are not fully understood.
Purpose of the Study:
- To investigate the immunogenic properties of staphylokinase.
- To determine if staphylokinase elicits T cell-dependent immune responses and immunological memory.
- To identify specific immunogenic regions of staphylokinase recognized by T cells.
Main Methods:
- Analysis of T cell proliferation in response to staphylokinase.
- Isolation and characterization of staphylokinase-specific T cell clones from multiple donors.
- Mapping of immunogenic regions recognized by T lymphocytes.
Main Results:
- Staphylokinase is a T cell-dependent antigen, inducing immunological memory.
- Thrombolysis with staphylokinase leads to sustained proliferation of specific T lymphocytes.
- Six distinct immunogenic regions were identified, with five recognized by T cells from multiple individuals, suggesting limited HLA-DR restriction.
Conclusions:
- Staphylokinase administration induces a T cell-dependent immune response and immunological memory.
- Specific immunogenic regions of staphylokinase have been mapped.
- These findings can guide the development of staphylokinase variants with reduced immunogenicity for improved clinical application.